Ga. Kaysen et al., EFFECT OF ONCOTIC PRESSURE ON APOLIPOPROTEIN-A-I METABOLISM IN THE RAT, American journal of kidney diseases, 26(1), 1995, pp. 178-186
The nephrotic syndrome is characterized by reduced plasma albumin and
colloid osmotic pressure (pi), urinary protein loss and hyperlipidemia
. High-density lipoprotein (HDL) and the level of apo A-I, the princip
al apolipoprotein in HDL, is increased in nephrotic rats and rats with
hereditary analbuminemia (NAR)-animals with virtually no albumin in p
lasma and reduced plasma pi, but without proteinuria, suggesting that
urinary protein loss is not responsible for increased plasma apo A-I l
evels. We conducted these studies to determine the mechanism responsib
le for increased plasma apo A-I levels in the nephrotic syndrome and N
AR and to determine whether reduced plasma pi or albumin was responsib
le for increased apo A-I. We first measured the clearance of I-125 apo
A-I HDL in NAR and rats with passive Heymann nephritis (HN) compared
with normal Sprague Dawley (SD) control. Both the clearance of apo A-I
and fractional apo A-I turnover rate (FTR) were significantly reduced
both in HN (7.40 +/- 2.18% plasma pool/hr) and NAR (5.63 +/- 1.12) co
mpared with SD (9.87 +/- 0.75). Total apo A-I turnover rate, which in
steady state equals apo A-I synthesis rate, was also significantly inc
reased in both HN (487 +/- 127 mu g/100 g body weight/hr) and NAR (253
+/- 16), compared with SD (216 +/- 19). Thus decreased apo A-I catabo
lism and increased synthesis both contributed to increased apo A-I lev
els in HN and NAR. We then infused either hyperoncotic human albumin o
r ficoll into two additional groups of HN for days in quantities suffi
cient to maintain plasma rr within the normal range. Both cholesterol
and apo A-I levels decreased to normal, even though proteinuria persis
ted, Thus apo A-I levels were increased both in HN and NAR as a result
of both increased synthesis and reduced catabolism in response to red
uced plasma pi. Neither hypoalbuminemia nor proteinuria were necessary
. (C) 1995 by the National Kidney Foundation, Inc.